Developmental Medicine and Child Neurology

Episódios Disponíveis

5 de 11

OCTOBER 2011: Predictive validity of Prechtl’s Method on the Qualitative Assessment of General Movements
The aim of this systematic review was to examine the evidence for the predictive validity of Prechtl’s Method on the Qualitative Assessment of General Movements (GMsA) with respect to neurodevelopmental outcomes. This paper: ‘Predictive validity of Prechtl’s Method on the Qualitative Assessment of General Movements: a systematic review of the evidence’ authored by Vasiliki Darsaklis, Laurie M Snider, Annette Majnemer, Barbara Mazer, published in the October issue of Developmental Medicine & Child Neurology, is discussed by Dr Peter Baxter, Editor in Chief of the journal, and two of the authors, Vasiliki Darsaklis (Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal (CRIR), School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada) and Laurie M Snider (School of Physical and Occupational Therapy, McGill University, and CRIR, Montreal Children’s Hospital, Montreal, QC, Canada). Read the paper: http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2011.04017.x/abstract
--------
26:00
--------
26:00
Cerebrospinal fluid B-cell expansion
A first episode of central nervous system (CNS) demyelination may represent heterogeneous entities such as acute disseminated encephalomyelitis, clinically isolated syndrome, neuromyelitis optica (NMO), or multiple sclerosis. As new immune therapies become available, it is increasingly important to make an early diagnosis. In this podcast, Editor in Chief of Developmental Medicine & Child Neurology, Dr Peter Baxter, talks to Professor Russell Dale (Clinical School, The Children’s Hospital at Westmead, Sydney) about the paper he co-authored in the September issue of the journal: 'Cerebrospinal fluid B-cell expansion in longitudinally extensive transverse myelitis associated with neuromyelitis optica immunoglobulin G' by Russell C Dale, Esther Tantsis, Vera Merheb, Fabienne Brilot. Read the paper:http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2011.03975.x/abstract
--------
23:03
--------
23:03
Developing and validating the Communication Function Classification System for individuals with cerebral palsy
The purpose of this study was to create and validate the Communication Function Classification System (CFCS) for children with cerebral palsy (CP), for use by a wide variety of individuals who are interested in CP. In this August podcast, Dr Peter Baxter speaks to Professor Mary Jo Cooley Heidecker (Assistant Professor, Department of Speech–Language Pathology, University of Central Arkansas, Conway, AR, USA) and Professor Peter Rosenabum (Professor of Paediatrics, McMaster University, Hamilton, Ontario, Canada), who were co-authors of the paper ‘Developing and validating the Communication Function Classification System for individuals with cerebral palsy’ by Mary Jo Cooley Hidecker, Nigel Paneth, Peter L Rosenbaum, Raymond D Kent, Janet Lillie, John B Eulenberg, Ken Chester, Jr, Brenda Johnson, Lauren Michalsen, Morgan Evatt, Kara Taylor. Read the paper: http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2011.03996.x/abstract Read the commentary: http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2011.04035.x/abstract
--------
23:47
--------
23:47
JULY 2011: Focus on function and context therapy
In this July podcast, Dr Peter Baxter, Editor in Chief of Developmental Medicine & Child Neurology discusses two papers: ‘Focus on function: a cluster, randomized controlled trial comparing child- versus context-focused intervention for young children with cerebral palsy’ by Mary C Law, Johanna Darrah, Nancy Pollock, Brenda Wilson, Dianne J Russell, Stephen D Walter, Peter Rosenbaum, Barb Galuppi, and ‘Context therapy: a new intervention approach for children with cerebral palsy’ by Johanna Darrah, Mary C Law, Nancy Pollock, Brenda Wilson, Dianne J Russell, Stephen D Walter, Peter Rosenbaum, Barb Galuppi. Dr Peter Baxter talks to Mary Law (School of Rehabilitation Science and CanChild Centre for Childhood Disability Research, McMaster University, Hamilton, Canada) and Eva Brogen Carlberg (Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden) who wrote a commentary in the July issue of Developmental Medicin3 & Child Neurology entitled: ‘Instead of certainty we have search …’. Read the papers: http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2011.03962.x/abstract http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2011.03959.x/abstract Read the commentary: http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2011.03979.x/abstract
--------
29:38
--------
29:38
JUNE 2011: Moving towards meaningful measurement
Reliable measurement of disease progression and the effect of therapeutic interventions in Duchenne muscular dystrophy (DMD) require clinically meaningful and scientifically sound rating scales. Therefore, we need robust evidence to support such tools. In this June 2011 podcast, Editor in Chief Dr Peter Baxter talks to Anna Mayhew (Institute of Human Genetics, International Centre for Life, Newcastle University, Newcastle upon Tyne, UK) and Mike Horton (Psychometric Laboratory for Health Sciences, Leeds, UK) about the following article: ‘Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy’ by Anna Mayhew, Stefan Cano, Elaine Scott, Michelle Eagle, Kate Bushby, Francesco Muntoni, On Behalf Of The North Star Clinical Network For Paediatric Neuromuscular Disease. Read the paper here: http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2011.03939.x/abstract
--------
23:35
--------
23:35